Pharmafile Logo
Pharmafocus logo
Advanced Search
Cream advert image

Genus reprimanded for ‘sexual and titillating’ advert

August 15, 2012
Sales and Marketing ABPI, Genus, PMCPA, breach, eczema

Genus has been found in breach of the ABPI Code after using a sexually charged image for the promotion of …

News

Smoke and fire in J&J Code breach

August 15, 2012
Sales and Marketing Champix, J&J, JJ, Johnson and Johnson, PMCPA, Pfizer

Johnson & Johnson has been censured for breaking the ABPI Code of Practice in printed information about its smoking cessation …

News
Patientslike me image

MSD joins forces with PatientsLikeMe for psoriasis

August 14, 2012
Medical Communications MSD, Novartis, PatientsLikeMe, digital, psoriasis

MSD has teamed up with the online patient community site ‘PatientsLikeMe’ to gauge the impact of psoriasis on patients, whilst …

News
Tsyabri image

Elan to spin off drug discovery arm

August 14, 2012
Research and Development, Sales and Marketing Elan, Neotype Biosciences, Tysabri, multiple sclerosis

Elan Corporation is to spin off its drug discovery arm Neotype Biosciences to create a separate, quoted company by the …

News
novartis_window

New Avastin data could be bad news for Lucentis

August 14, 2012
Research and Development, Sales and Marketing DMO, Lucentis, Novartis, Roche, avastin, off label, off-label, wet AMD

The day after Novartis gained a new US licence for Lucentis to treat diabetic macular oedema, new data was published …

News

China sets February 2013 deadline for excipient regulations

August 14, 2012
Manufacturing and Production China, IPEC, SFDA, Taylor

China has moved swiftly ahead with new regulations governing quality rules for pharmaceutical excipients, including new requirements for pharma firms …

News
dr_susan_wood

Astellas Pharma Europe appoints new senior director

August 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Susan Wood

Astellas Pharma Europe has appointed Dr Susan Wood as senior director, Market Access. Formerly senior brand director of APEL’s Pain Management …

Appointment

Acino plant opens to serve Bayer contraceptive patch needs

August 14, 2012
Manufacturing and Production Acino, Bayer, R&D, Swiss, contraceptive

Acino has officially opened its new manufacturing facility for transdermal patch products in Miesbach, Germany, which it says makes it …

News

Novartis pledges to maintain R&D presence in Horsham

August 14, 2012
Manufacturing and Production, Research and Development Horsham, NIBR, Novartis, R&D, cuts

Novartis has confirmed that it intends to maintain a presence at its site in Horsham, UK, which has already seen …

News
Nexium image

Pfizer pays $250m for OTC Nexium rights

August 14, 2012
Sales and Marketing AstraZeneca, EMA, FDA, Nexium, OTC, Pfizer

Pfizer will pay $250 million to AstraZeneca in order to gain the rights to sell an over-the-counter form of the …

News

Pharma manufacturing news in brief

August 14, 2012
Manufacturing and Production Advanced Bioscience, Almac, Amneal, Cipla, Isis, Sanofi Pasteur

Cipla opening three new API plants as Indian trade delegations forges closer ties with Sri Lanka; plus facility updates from …

News
Amgen image

Amgen unveils plan to close Epogen plant

August 14, 2012
Manufacturing and Production Amgen, Epogen, cuts, omontys

Amgen has said it will close down a manufacturing facility in Longmont, Colorado, in the face of declining sales of …

News

De Facto in management buy out

August 14, 2012
Medical Communications Chime Communications, De Facto Communications

Healthcare and life sciences communications specialist De Facto Communications has completed a management buyout of the business from Chime Communications.The …

News

WuXi continues strong growth

August 14, 2012
Manufacturing and Production China, WuXi

Chinese contract research firm Wuxi saw its revenue grow strongly in the second quarter, with its laboratory services playing a …

News
Avastin image

Avastin sees success in brain cancer trial

August 13, 2012
Research and Development, Sales and Marketing R&D, avastin, brain cancer

A late-stage study has shown that Roche’s oncology drug Avastin, when added to standard therapy, can help people with brain …

News
Pfizer image

Torisel-Avastin combo fails in kidney cancer

August 13, 2012
Research and Development, Sales and Marketing R&D, Sutent, Torisel, avastin, failure, rcc

Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to …

News
Lucentis image

Lucentis gains new licence in the US

August 13, 2012
Sales and Marketing Eylea, FDA, Lucentis, approval, avastin, wet AMD

Roche’s eye drug Lucentis has gained a new licence in the US to treat diabetic macular oedema. The FDA has …

News

Contract research news in brief

August 10, 2012
Research and Development Accenture, Charles River Labs, ICON, Octagon Research Solutions, Phlexglobal, Quanticate, Verum

ICON plans UK investment, Verum expands in the US, plus updates from Charles River, Phlexglobal, Accenture/Octagon and Quanticate.

News
merck serono image

Merck Serono says dispute over Geneva closure is resolved

August 10, 2012
Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts

Merck Serono says it has reached agreement with groups representing workers affected by the closure and downsizing of sites in …

News
FDA image

FDA approves leukaemia drug Marqibo

August 10, 2012
Sales and Marketing FDA, Marqibo, Talon Therapeutics, lilly

The Food and Drug Administration has given the green light for Talon Therapeutics’ Marqibo to combat a rare form of …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026